QQ客服 官方微博 反馈留言

	Combination of low-dose docetaxel and standard-dose S-1 for the treatment of advanced gastric cancer: efficacy, toxicity, and potential predictive factor
	Cui, Yuehong; Li, Qian; Yu, Yiyi; Chen, Yong; Feng, Yi; Wang, Yan; Liu, Tianshu
刊名	CANCER CHEMOTHERAPY AND PHARMACOLOGY
	2013
卷号	71期号:1
关键词	Gastric cancer Chemotherapy Dihydropyrimidine dehydrogenase
ISSN号	0344-5704
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4902921
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Cui, Yuehong,Li, Qian,Yu, Yiyi,et al. Combination of low-dose docetaxel and standard-dose S-1 for the treatment of advanced gastric cancer: efficacy, toxicity, and potential predictive factor[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY,2013,71(1).
APA	Cui, Yuehong.,Li, Qian.,Yu, Yiyi.,Chen, Yong.,Feng, Yi.,...&Liu, Tianshu.(2013).Combination of low-dose docetaxel and standard-dose S-1 for the treatment of advanced gastric cancer: efficacy, toxicity, and potential predictive factor.CANCER CHEMOTHERAPY AND PHARMACOLOGY,71(1).
MLA	Cui, Yuehong,et al."Combination of low-dose docetaxel and standard-dose S-1 for the treatment of advanced gastric cancer: efficacy, toxicity, and potential predictive factor".CANCER CHEMOTHERAPY AND PHARMACOLOGY 71.1(2013).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。